Discovery of Potential Neuroprotective Agents against Paclitaxel-Induced Peripheral Neuropathy
Chemotherapy-induced neurotoxicity is a common adverse effect of cancer treatment. No medication has been shown to be effective in the prevention or treatment of chemotherapy-induced neurotoxicity. Using minoxidil as an initial template for structural modifications in conjunction with an in vitro neurite outgrowth assay, an image-based high-content screening platform, and mouse behavior models, an effective neuroprotective agent CN016 was discovered. Our results showed that CN016 could inhibit paclitaxel-induced inflammatory responses and infiltration of immune cells into sensory neurons significantly. Thus, the suppression of proinflammatory factors elucidates, in part, the mechanism of action of CN016 on alleviating paclitaxel-induced peripheral neuropathy. Based on excellent efficacy in improving behavioral functions, high safety profiles (MTD > 500 mg/kg), and a large therapeutic window (MTD/MED > 50) in mice, CN016 might have great potential to become a peripherally neuroprotective agent to prevent neurotoxicity caused by chemotherapeutics as typified by paclitaxel.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:65 |
---|---|
Enthalten in: |
Journal of medicinal chemistry - 65(2022), 6 vom: 24. März, Seite 4767-4782 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chen, Yi-Fan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antineoplastic Agents |
---|
Anmerkungen: |
Date Completed 06.05.2022 Date Revised 06.05.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1021/acs.jmedchem.1c01912 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM337657424 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM337657424 | ||
003 | DE-627 | ||
005 | 20231225234921.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1021/acs.jmedchem.1c01912 |2 doi | |
028 | 5 | 2 | |a pubmed24n1125.xml |
035 | |a (DE-627)NLM337657424 | ||
035 | |a (NLM)35234475 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chen, Yi-Fan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Discovery of Potential Neuroprotective Agents against Paclitaxel-Induced Peripheral Neuropathy |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.05.2022 | ||
500 | |a Date Revised 06.05.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Chemotherapy-induced neurotoxicity is a common adverse effect of cancer treatment. No medication has been shown to be effective in the prevention or treatment of chemotherapy-induced neurotoxicity. Using minoxidil as an initial template for structural modifications in conjunction with an in vitro neurite outgrowth assay, an image-based high-content screening platform, and mouse behavior models, an effective neuroprotective agent CN016 was discovered. Our results showed that CN016 could inhibit paclitaxel-induced inflammatory responses and infiltration of immune cells into sensory neurons significantly. Thus, the suppression of proinflammatory factors elucidates, in part, the mechanism of action of CN016 on alleviating paclitaxel-induced peripheral neuropathy. Based on excellent efficacy in improving behavioral functions, high safety profiles (MTD > 500 mg/kg), and a large therapeutic window (MTD/MED > 50) in mice, CN016 might have great potential to become a peripherally neuroprotective agent to prevent neurotoxicity caused by chemotherapeutics as typified by paclitaxel | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Antineoplastic Agents |2 NLM | |
650 | 7 | |a Antineoplastic Agents, Phytogenic |2 NLM | |
650 | 7 | |a Neuroprotective Agents |2 NLM | |
650 | 7 | |a Paclitaxel |2 NLM | |
650 | 7 | |a P88XT4IS4D |2 NLM | |
700 | 1 | |a Wu, Chien-Huang |e verfasserin |4 aut | |
700 | 1 | |a Chen, Li-Hsien |e verfasserin |4 aut | |
700 | 1 | |a Lee, Hao-Wei |e verfasserin |4 aut | |
700 | 1 | |a Lee, Jinq-Chyi |e verfasserin |4 aut | |
700 | 1 | |a Yeh, Teng-Kuang |e verfasserin |4 aut | |
700 | 1 | |a Chang, Jang-Yang |e verfasserin |4 aut | |
700 | 1 | |a Chou, Ming-Chen |e verfasserin |4 aut | |
700 | 1 | |a Wu, Hui-Ling |e verfasserin |4 aut | |
700 | 1 | |a Lai, Yen-Po |e verfasserin |4 aut | |
700 | 1 | |a Song, Jen-Shin |e verfasserin |4 aut | |
700 | 1 | |a Yeh, Kai-Chia |e verfasserin |4 aut | |
700 | 1 | |a Chen, Chiung-Tong |e verfasserin |4 aut | |
700 | 1 | |a Lee, Chia-Jui |e verfasserin |4 aut | |
700 | 1 | |a Shia, Kak-Shan |e verfasserin |4 aut | |
700 | 1 | |a Shen, Meng-Ru |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of medicinal chemistry |d 1963 |g 65(2022), 6 vom: 24. März, Seite 4767-4782 |w (DE-627)NLM000006602 |x 1520-4804 |7 nnns |
773 | 1 | 8 | |g volume:65 |g year:2022 |g number:6 |g day:24 |g month:03 |g pages:4767-4782 |
856 | 4 | 0 | |u http://dx.doi.org/10.1021/acs.jmedchem.1c01912 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 65 |j 2022 |e 6 |b 24 |c 03 |h 4767-4782 |